Scopus BioPharma SCPS

$ 0.18 -48.37%

Quarterly report 2023-Q2
added 08-11-2023

Scopus BioPharma Balance Sheet 2011-2024 | SCPS

Annual Balance Sheet Scopus BioPharma

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	452 K	-36.7 K	-1.66 K	-158 K	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	7.45 M	4.17 M	3.81 M	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	3.81 M	855 K	138 K	111 K	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-53.1 M	-41.5 M	-14.5 M	-3.64 M	-949 K	-264 K	-	-	-	-	-	-
Total Assets	392 K	8.19 M	1.97 M	772 K	133 K	213 K	-	-	-	-	-	-
Cash and Cash Equivalents	125 K	7.94 M	1.83 M	36.7 K	-	-	-	-	-	-	-	-
Book Value	392 K	8.19 M	-1.83 M	-82.9 K	-5.33 K	102 K	-	-	-	-	-	-
Total Shareholders Equity	-6.56 M	4.02 M	-1.83 M	-82.9 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Scopus BioPharma

	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-58.1 M	-55.5 M	-53.1 M	-51.3 M	-49.4 M	-46.1 M	-41.5 M	-34.9 M	-33.5 M	-17.9 M	-14.5 M	-14.5 M	-14.5 M	-14.5 M	-3.64 M	-3.64 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	498 K	1.6 M	392 K	416 K	1.67 M	4.61 M	8.19 M	4.03 M	6.81 M	8.63 M	1.97 M	1.97 M	1.97 M	1.97 M	772 K	772 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	362 K	1.4 M	125 K	311 K	1.16 M	3.97 M	7.94 M	3.63 M	6.26 M	8.26 M	1.83 M	1.83 M	1.83 M	1.83 M	36.7 K	36.7 K	-	-	1.66 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	498 K	1.6 M	392 K	416 K	1.67 M	4.61 M	8.19 M	4.03 M	6.81 M	8.63 M	1.97 M	1.97 M	1.97 M	1.97 M	772 K	772 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-9.45 M	-7.71 M	-6.56 M	-5.5 M	-3.7 M	-530 K	4.02 M	1.79 M	-1.98 M	4.15 M	-1.83 M	-1.83 M	-1.83 M	-1.83 M	-82.9 K	-82.9 K	1.1 M	-	-5.33 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency